Q&A

First-trimester tests for trisomies 21 and 18 as sensitive as triple screen

Author and Disclosure Information

  • BACKGROUND: Women who are deemed to have abnormal calculated risks for trisomy 21 (Down syndrome—the most common trisomy) or trisomy 18 (Edwards syndrome, a much less common but more severe type of aneuploid pregnancy) and elect to undergo second-trimester triple screening are counseled on ultrasound and confirmatory fetal karyotype testing, typically amniocentesis.
  • POPULATION STUDIED: Women at 12 academic prenatal diagnostic centers in the US and Canada who were between 10 4/7 and 13 6/7 weeks gestation were offered first-trimester screening if they met inclusion criteria: a singleton gestation that was not the product of a donor oocyte, no significant recent vaginal bleeding, no other indications for prenatal diagnosis, and no diabetes. A total of 8816 eligible patients consented.
  • STUDY DESIGN AND VALIDITY: First-trimester screening consisted of maternal serum measurements of free beta human chorionic gonadotropin and pregnancy-associated plasma protein A, along with ultrasonographic measurement of fetal nuchal translucency. These biochemical markers and ultrasound measurement were analyzed independently and together to compute patient-specific risks.
  • OUTCOMES MEASURED: The primary study outcomes were sensitivity and specificity of the first-trimester screening tools as determined by knowledge of fetal karyotype or newborn phenotype.
  • RESULTS: The investigators found that a combination of maternal age, the 2 serum markers, and nuchal translucency in the first trimester was 89% sensitive and 89% specific for identification of trisomy 18 (11 cases) or 21 (61 cases). The stated sensitivity and specificity of second-trimester triple screen for trisomy 21 are 65% and 95%, respectively.


 

PRACTICE RECOMMENDATIONS

First-trimester screening for trisomies 21 and 18 with maternal serum markers and ultra-sonographic measurement of fetal nuchal translucency is more sensitive than second-trimester “triple screen.” Application of this finding to general practice is limited by lack of access to radiologists trained in this more specialized prenatal ultrasound measurement.

Recommended Reading

Should we screen for ovarian cancer?
MDedge Family Medicine
Water versus gel lubricant for cervical cytology specimens
MDedge Family Medicine
Metoclopramide reduces nausea from emergency contraception
MDedge Family Medicine
Clindamycin for vaginosis reduces prematurity and late miscarriage
MDedge Family Medicine
Zonisamide effective for weight loss in women
MDedge Family Medicine
Continuous use of oral contraceptives reduces bleeding
MDedge Family Medicine
Estrogen plus progestin may increase incidence of dementia
MDedge Family Medicine
Which cytology results predict cervical intraepithelial neoplasia?
MDedge Family Medicine
Routine induction reduces cesarean rate
MDedge Family Medicine
Aspirin prevents preeclampsia and complications
MDedge Family Medicine